PNC FINANCIAL SERVICES GROUP, INC. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$107,824
-29.8%
3,410
-9.5%
0.00%
Q2 2023$153,618
+17.5%
3,767
+7.4%
0.00%
Q1 2023$130,707
+6.1%
3,507
-0.7%
0.00%
Q4 2022$123,233
-37.8%
3,532
+1.0%
0.00%
Q3 2022$198,000
+9.4%
3,497
-0.5%
0.00%
Q2 2022$181,000
-67.0%
3,514
-53.5%
0.00%
Q1 2022$549,000
-67.5%
7,557
-47.1%
0.00%
-100.0%
Q4 2021$1,691,000
-29.2%
14,297
-19.7%
0.00%
-50.0%
Q3 2021$2,389,000
-20.6%
17,810
-4.2%
0.00%
-33.3%
Q2 2021$3,010,000
+102.1%
18,592
+0.2%
0.00%
+200.0%
Q1 2021$1,489,000
+49.2%
18,556
+1.1%
0.00%0.0%
Q4 2020$998,000
+275.2%
18,358
+37.4%
0.00%
Q3 2020$266,0000.0%13,358
+5.2%
0.00%
Q2 2020$266,000
-4.3%
12,700
-44.1%
0.00%
Q1 2020$278,000
-5.4%
22,700
+13.5%
0.00%
Q4 2019$294,000
+145.0%
20,000
+121.0%
0.00%
Q3 2019$120,000
-26.8%
9,050
-9.5%
0.00%
Q2 2019$164,000
-8.4%
10,000
-4.6%
0.00%
Q1 2019$179,000
+31.6%
10,485
+4.8%
0.00%
Q4 2018$136,000
+6700.0%
10,000
+9900.0%
0.00%
Q3 2017$2,0000.0%1000.0%0.00%
Q2 2017$2,0000.0%1000.0%0.00%
Q1 2017$2,0000.0%1000.0%0.00%
Q4 2016$2,0000.0%1000.0%0.00%
Q3 2016$2,0000.0%1000.0%0.00%
Q2 2016$2,0001000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders